Twice-yearly shots used to treat AIDS could soon be the key to preventing new infections.

This according to a study published in the New England Journal of Medicine.

The data was concluded from a sample of about 5,000 young women and girls in South Africa and Uganda.

Last year, a report by UNICEF revealed that young women and girls are more than twice as likely to contract HIV than young men and boys.

For more, Peter Ndoro spoke to Prof Linda Gail Bekker- Director of the Desmond Tutu HIV centre and national principal investigator of purpose 1 trial.

Twice-yearly shots used to treat AIDS could soon be the key to preventing new infections.
This according to a study published in the New England Journal of Medicine.
The data was concluded from a sample of about 5,000 young women and girls in South Africa and Uganda.
Last year, a report by UNICEF revealed that young women and girls are more than twice as likely to contract HIV than young men and boys.
For more, Peter Ndoro spoke to Prof Linda Gail Bekker- Director of the Desmond Tutu HIV centre and national principal investigator of purpose 1 trial.

Africa Rise & Shine

Twice-yearly shots could soon be the key to preventing new HIV infections

The African Union Development Agency-NEPAD's African Medicines Regulatory Harmonisation Programme is marking a significant milestone this week with its first Continental Dossier Assessment Plenary.

The programme is piloting a new medicine evaluation process to ensure that medicines reaching the African people are of the highest quality.

In collaboration with the Good Manufacturing Practices Technical Committee over 100 dossier assessors from across Africa are gathering in the Kwa-Zulu Natal province of South Africa for the first continental dossier plenary session.

To chat to us further on this issue is Farai Masekela the Chairperson of the Evaluation of Medicinal Products Technical Committee.

The African Union Development Agency-NEPAD's African Medicines Regulatory Harmonisation Programme is marking a significant milestone this week with its first Continental Dossier Assessment Plenary.
The programme is piloting a new medicine evaluation process to ensure that medicines reaching the African people are of the highest quality.
In collaboration with the Good Manufacturing Practices Technical Committee over 100 dossier assessors from across Africa are gathering in the Kwa-Zulu Natal province of South Africa for the first continental dossier plenary session.
To chat to us further on this issue is Farai Masekela the Chairperson of the Evaluation of Medicinal Products Technical Committee.

NEPAD pilots new medicine evaluation process

The Botswana Ministry of Minerals has placed before parliament its proposal for a new legislation that allow locals to purchase a 24 percent stake from mining companies.

The draft bill indicates that this mandate will apply if the government opts not to exercise its right to acquire the same shareholding.

Furthermore, the proposal aims to amend the current Mines and Minerals Act, which permits the Botswana government to acquire a 15 percent interest in mining projects upon licensing.

To further make sense of all this and unpack what this means for the people of Botswana and its government, Peter Ndoro spoke to Botswana's Sunday Standard Newspaper Business Editor, Victor Baatweng.

The Botswana Ministry of Minerals has placed before parliament its proposal for a new legislation that allow locals to purchase a 24 percent stake from mining companies.
The draft bill indicates that this mandate will apply if the government opts not to exercise its right to acquire the same shareholding.
Furthermore, the proposal aims to amend the current Mines and Minerals Act, which permits the Botswana government to acquire a 15 percent interest in mining projects upon licensing.
To further make sense of all this and unpack what this means for the people of Botswana and its government, Peter Ndoro spoke to Botswana's Sunday Standard Newspaper Business Editor, Victor Baatweng.

Botswana Ministry of Minerals has proposed new legislation to allow locals to purchase a 24% stake from mining companies

A New study shows that great strides have been made in controlling HIV virus in South Africa.

The southern African nation faces a sobering reality as it has the highest number of people living with HIV globally.

This stark truth highlights a critical disparity in global health research - the severe underrepresentation of African genomes in scientific studies.

African populations have for too long been overlooked in the search for breakthroughs in disease understanding and treatment, despite their genetic diversity holding invaluable clues to unlocking solutions for some of the world's most pressing health challenges.

For more on this, leading researcher in HIV human genetics, Senior Lecturer at the University of KwaZulu-Natal and a five-year Harvard Scholar, DR Veron Ramsuran spoke to Aurelie Kalenga.

A New study shows that great strides have been made in controlling HIV virus in South Africa.
The southern African nation faces a sobering reality as it has the highest number of people living with HIV globally.
This stark truth highlights a critical disparity in global health research - the severe underrepresentation of African genomes in scientific studies.
African populations have for too long been overlooked in the search for breakthroughs in disease understanding and treatment, despite their genetic diversity holding invaluable clues to unlocking solutions for some of the world's most pressing health challenges.
For more on this, leading researcher in HIV human genetics, Senior Lecturer at the University of KwaZulu-Natal and a five-year Harvard Scholar, DR Veron Ramsuran spoke to Aurelie Kalenga.

Twice-yearly shots could soon be the key to preventing new HIV infections

In 1 playlist(s)

Africa Rise & Shine

Recent clips